‘Game-changing’ new treatment for cancer patients available in Canada

Source: www.ctvnews.ca Author: Jackie Vandinther, Digital Content Editor In the last three years, David Hutson has beaten both throat and skin cancer. Now he’s hoping a new form of radiation treatment will help him overcome the prostate cancer he was diagnosed with last September. Hutson is the first patient in the world to experiment with a new cancer-killing technology called MR-Linac. Radiologists from the Christie Hospital Manchester in the United Kingdom help cancer patient David Hutson out of the MR-Linac radiation machine in Manchester, U.K. in May 2019 Patient David Hutson receives radiation treatment for his prostate cancer using an MR-Linac machine at the Christie Hospital Manchester in Manchester, the United Kingdom in May 2019. (ITN) "I feel very lucky indeed that I'm having this treatment. I feel very confident in this technology,” he says from the Christie Hospital Manchester in the United Kingdom. "And from my diagnosis, it's going to help me to defeat this third bout of cancer." Normally, radiotherapy is carried out in two stages. First, a scan of the tumour is made. Then a dose of radiation is delivered. Part MRI scanner and part radiation machine, the MR-Linac allows doctors to do both tasks at once; they can visualize the tumour in real time while beaming high-energy radiation to the area. The result is on-the-spot imaging and targeted treatment in one shot. Because doctors can give more precise and intense doses of radiation, the groundbreaking technology could treat cancers with unprecedented safety [...]

A new way to predict complications after larynx cancer surgery

Source: www.eurekalert.org Author: News release - Michigan Medicine, University of Michigan Rebecca Hoesli, M.D., and Matthew Spector, M.D., evaluate an image from the studey A technique that illuminates blood flow during surgery predicted which head and neck cancer patients were likely to have issues with wound healing. It could enable surgeons to make adjustments during surgery or recovery to improve outcomes. A team of surgeons at the University of Michigan Rogel Cancer Center found the approach so successful in a clinical trial that they closed the study early. Most people with larynx cancer will have radiation and chemotherapy. But about one-third of the time, the cancer will return or will prove resistant, leaving surgery as the next option. At this point, tissue damage from the radiation adds challenges to the operation. When the surgeon closes the wound, damaged tissue can interfere. For about 40% of patients, this will lead to a pharyngocutaneous fistula, a hole in the neck where saliva can leak out. It can cause bleeding or infections, keeping patients in the hospital longer, and in 10% of cases sending them back to the operating room to fix it. "Radiation damage is something you can't always see. There have been very few examples in the literature that would explain or predict who's going to have a complication," says Matthew E. Spector, M.D., assistant professor of otolaryngology-head and neck surgery at Michigan Medicine. Spector is the senior author on a paper made available online in February ahead of [...]

Go to Top